You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is The following drugs can produce ototoxicity except: and explain in detail?
ESSENTIALS of medical PHARMOCOLOGY SEVENTH EDITION K. D TRaiPATHI Page:730 MONOBACTAMS Aztreonam It is a novel b-lactam antibiotic in which the other ring is missing (hence mono- bactam). It inhibits gram-negative enteric bacilli and H. influenzae at very low concentrations and Pseudomonas at moderate concentrations, but does not inhibit gram-positive cocci or faecal anaerobes. Thus, it is a b-lactam antibiotic with a spectrum resembling aminoglycosides. It is resistant to gram-negative b lactamases. The main indications of aztreonam are hospital- acquired infections originating from urinary, biliary, gastrointestinal and female genital tracts. Lack of cross sensitivity with other blactam antibiotics except possibly ceftazidime is the most prominent feature of aztreonam: permiting its use in patients allergic to penicillins or cephalo- sporins. Rashes and rise in serum aminotrans- ferases are the notable adverse effects. It is eliminated in urine with a tlfz of 1.8 hr. Dose: 0.5-2 g i.m. or i.v. 6-12 hourly. AZENAM, TREZAM 0.5, 1 .0, 2.0 g/l inj .